174 related articles for article (PubMed ID: 34101795)
1. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
Kosaner Kließ M; Martins R; Connolly MP
J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
[TBL] [Abstract][Full Text] [Related]
2. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
[TBL] [Abstract][Full Text] [Related]
3. Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Treuer T; Sato M; Kahle-Wrobleski K; Meguro K; Yamada M; Mimura M; Arai H
J Alzheimers Dis; 2020; 74(1):127-138. PubMed ID: 31985460
[TBL] [Abstract][Full Text] [Related]
4. Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia.
Belger M; Haro JM; Reed C; Happich M; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
Eur J Health Econ; 2019 Apr; 20(3):343-355. PubMed ID: 30178148
[TBL] [Abstract][Full Text] [Related]
5. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
[TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
[TBL] [Abstract][Full Text] [Related]
7. Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study.
Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Matsumura T; Meguro K; Yamada M; Mimura M; Arai H; Treuer T
Curr Med Res Opin; 2021 Aug; 37(8):1331-1339. PubMed ID: 33904362
[TBL] [Abstract][Full Text] [Related]
8. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden of Alzheimer's Disease Dementia in Japan.
Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
[TBL] [Abstract][Full Text] [Related]
12. Relation between severity of Alzheimer's disease and costs of caring.
Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
[TBL] [Abstract][Full Text] [Related]
13. Determinants of costs of care for patients with Alzheimer's disease.
Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care.
Gervès C; Chauvin P; Bellanger MM
Health Policy; 2014 May; 116(1):114-22. PubMed ID: 24461717
[TBL] [Abstract][Full Text] [Related]
15. Caregivers' Sense of Coherence: Implications on Direct and Indirect Costs of Dementia Care.
Turró-Garriga O; Viñas-Díez V; Conde-Sala JL; Calvó-Perxas L; Cullell-Juncà M; Mas-Vall-Llosera G; Flaqué M; Turon-Estrada A; Juvinyà-Canal D; Mioshi E; Garre-Olmo J
J Alzheimers Dis; 2020; 78(1):117-126. PubMed ID: 32925037
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease care: costs and potential savings.
Leon J; Cheng CK; Neumann PJ
Health Aff (Millwood); 1998; 17(6):206-16. PubMed ID: 9916370
[TBL] [Abstract][Full Text] [Related]
17. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease.
Marin D; Amaya K; Casciano R; Puder KL; Casciano J; Chang S; Snyder EH; Cheng I; Cuccia AJ
Int Psychogeriatr; 2003 Dec; 15(4):385-98. PubMed ID: 15000418
[TBL] [Abstract][Full Text] [Related]
18. Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.
Turró-Garriga O; Garre-Olmo J; Reñé-Ramírez R; Calvó-Perxas L; Gascón-Bayarri J; Conde-Sala JL
J Alzheimers Dis; 2016 Oct; 54(4):1551-1560. PubMed ID: 27636844
[TBL] [Abstract][Full Text] [Related]
19. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]